AzTrials
AzTrials

White Matter InjuryNCT04508517

Brain White Matter Injury in Late Preterm Infants

An observational study of White Matter Injury, run by Shengjing Hospital at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

At 34 weeks, the brain weight of preterm infants is only 65% that of term infants, and the cortex volume is 53% that of term infants. Damage at this stage of development will also change the trajectory of specific processes in the development of neurons and glial cells, resulting in neurological dysfunction in… Read more about this study

Who is it for?
Ages 1 day to 28 days
Conditions the study is for
White Matter Injury
How many people
3,000 participants
Where
1 siteChina
Study dates
Jan 2009to Dec 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 day to 28 days
  • All sexes
  • No healthy volunteers
  • Child

Study population: Late preterm infants undergoing head MRI, who were hospitalized in Shengjing Hospital from 1st January 2009 to 31st December 2022, were enrolled in this study.

Who may be able to join

  • MRI head examination with informed consent of guardian
  • Age 34-36+6 weeks

Who cannot join

  • Other encephalopathies or congenital abnormality of brain development except white matter injury were excluded

Trial locations and contacts

1 site in 1 country.

Dan Chen, master contact

+8618940259088

youdrop@sina.com

China1 site, 1 recruiting
  • Shengjing Hospital of China Medical University

    Shenyang, Liaoning, 110004

    Chen Chen, master, +8618940259088, youdrop@sina.com

    Recruiting

Other trials in China

About this study

Official title: A Cohort Study on the Etiology and Pathological Types of Brain White Matter Injury in Late Preterm Infants

At 34 weeks, the brain weight of preterm infants is only 65% that of term infants, and the cortex volume is 53% that of term infants. Damage at this stage of development will also change the trajectory of specific processes in the development of neurons and glial cells, resulting in neurological dysfunction in survivors.The incidence of cerebral palsy in late preterm infants is three times higher than in term infants, and about 25% lag behind term infants in learning, language and other neurodevelopment. At 34-37 weeks of gestation, oligodendrocytes are still late oligodendrocyte precursors and vascular development of the white matter area is immature, making the brain more prone to white matter injury (WMI).

Read the detailed description

1.1Patients Late preterm infants who were hospitalized in Shengjing Hospital from 1st January 2009 to 31st December 2022.

Risk factors prompting MRI evaluation included: (1) premature rupture of fetal membrane, intrauterine distress or placental abruption before delivery; (2) asphyxia, resuscitation and rescue history, circulatory dysfunction and infection during or after delivery; and (3) early convulsions.

1.2 Assessment of brain injury MRI scans were analyzed by a radiologist and a newborn pediatrician who were unfamiliar with the clinical history. WMI diagnosis was carried out as described by reference, with some improvements.

1.3 Collection of clinical data Data, including delivery by cesarean section, gestational hypertension, diabetes mellitus, premature rupture of membranes and placental abruption, were collected for the mothers. Gestational age, weight, gender, whether small for gestational age, Apgar score, resuscitation history, circulatory disorders, early-onset sepsis, convulsions, and MRI data were collected for the newborns.

History of resuscitation and rescue refers to positive pressure ventilation, tracheal intubation, chest compression or epinephrine application during labor; circulatory disorders include at least two of the following indicators: prolonged capillary filling time, hypotension, oliguria, increased heart rate and increased liver.

1.4 Instrumentation MRI of the head was performed using an Intera Achieva 3.0T MRI system (Philips, Best, Netherlands). All infants were scanned by conventional MRI and diffusion-weighted imaging (DWI). Because of the retrospective study design, there are differences in imaging schemes, sequences and parameters measured.

Keywords
white matter injury;late preterm infants

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Imaging evaluation of different types of white matter injury in late preterm infants

    The number of participants of white matter injury in late preterm infants, number of late preterm infants with different degrees (mild, moderate, severe) white matter injury and the imaging and pathological characteristics of early white matter injury (within 2 weeks after birth) using T1WI,T2WI,DWI,SWI.

    Measured: 2009.1-2022.12

  2. Imaging differentiation of hemorrhagic and non hemorrhagic injuries

    Using magnetic resonance technology, especially magnetic sensitivity, to identify and classify the cases of white matter injury in late preterm infants with or without hemorrhagic injury

    Measured: 2009.1-2022.12

  3. Number of late preterm infants and distribution of gray matter injury in late preterm infants with white matter injury

    Using magnetic resonance technology, To determine the number of gray matter injuries (cortex, thalamus, basal ganglia, brainstem) in late preterm infants with white matter injury

    Measured: 2009.1-2022.12

  4. The number and distribution of PVL like injury in white matter injury of late preterm infants

    Using magnetic resonance technology, to determine the probability of PVL-like injury in white matter injury of late preterm infants and which type and location are more prone to PVL-like outcomes

    Measured: 2009.1-2022.12

Secondary outcomes (14)
  1. Record of gestational age

    To identify the high risk factors of brain white matter injury in late preterm infants,gestational age(weeks) of every late preterm infant will be recorded

    Measured: 2009.1-2022.12

  2. Record of weight

    To identify the high risk factors of brain white matter injury in late preterm infants,weight(g) of every late preterm infant will be recorded

    Measured: 2009.1-2022.12

  3. Record of gender

    To identify the high risk factors of brain white matter injury in late preterm infants, gender(male/female) of every late preterm infant will be recorded

    Measured: 2009.1-2022.12

  4. Record of small for gestational age

    To identify the high risk factors of brain white matter injury in late preterm infants,whether small for gestational age(yes/no) of every late preterm infant will be recorded

    Measured: 2009.1-2022.12

  5. Record of apgar score

    To identify the high risk factors of brain white matter injury in late preterm infants,Apgar score(1-10) of every late preterm infant will be recorded

    Measured: 2009.1-2022.12

  6. Number of resuscitation history

    To identify the high risk factors of brain white matter injury in late preterm infants,resuscitation history(yes/no) of every late preterm infant will be recorded.History of resuscitation and rescue refers to positive pressure ventilation, tracheal intubation, chest compression or epinephrine application during labor

    Measured: 2009.1-2022.12

  7. Number of circulatory disorders

    To identify the high risk factors of brain white matter injury in late preterm infants,circulatory disorders(yes/no) of every late preterm infant will be recorded.Circulatory disorders include at least two of the following indicators: prolonged capillary filling time, hypotension, oliguria, increased heart rate and increased liver.

    Measured: 2009.1-2022.12

  8. Number of early-onset sepsis

    To identify the high risk factors of brain white matter injury in late preterm infants,early-onset sepsis(yes/no) of every late preterm infant will be recorded

    Measured: 2009.1-2022.12

  9. Number of convulsions

    To identify the high risk factors of brain white matter injury in late preterm infants,convulsions(yes/no) of every late preterm infant will be recorded

    Measured: 2009.1-2022.12

  10. Record of delivery by cesarean section

    To identify the high risk factors of brain white matter injury in late preterm infants,delivery by cesarean section(yes/no) of every mother will be recorded

    Measured: 2009.1-2022.12

  11. Number of gestational hypertension

    To identify the high risk factors of brain white matter injury in late preterm infants,gestational hypertension(mmHg) of every mother will be recorded

    Measured: 2009.1-2022.12

  12. Number of diabetes mellitus

    To identify the high risk factors of brain white matter injury in late preterm infants,diabetes mellitus(yes/no) of every mother will be recorded

    Measured: 2009.1-2022.12

  13. Number of premature rupture of membranes

    To identify the high risk factors of brain white matter injury in late preterm infants,premature rupture of membranes(yes/no) of every mother will be recorded

    Measured: 2009.1-2022.12

  14. Number of placental abruption

    To identify the high risk factors of brain white matter injury in late preterm infants,placental abruption(yes/no) of every mother will be recorded

    Measured: 2009.1-2022.12

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Aug 2020
  2. Study startJan 2009
  3. Primary completionJun 2022 (estimated)
  4. Study completionDec 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Other
Enrolment
3,000 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04508517
Sponsor's protocol ID
DChen
Status last verified
Aug 2020
First submitted
3 Aug 2020
Last updated
11 Aug 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Sharing the imaging results.

Publications

  • Kinney HC. The near-term (late preterm) human brain and risk for periventricular leukomalacia: a review. Semin Perinatol. 2006 Apr;30(2):81-8. doi: 10.1053/j.semperi.2006.02.006.

    PubMed 16731282
  • Petrini JR, Dias T, McCormick MC, Massolo ML, Green NS, Escobar GJ. Increased risk of adverse neurological development for late preterm infants. J Pediatr. 2009 Feb;154(2):169-76. doi: 10.1016/j.jpeds.2008.08.020. Epub 2008 Dec 10.

    PubMed 19081113
  • Limperopoulos C, Soul JS, Gauvreau K, Huppi PS, Warfield SK, Bassan H, Robertson RL, Volpe JJ, du Plessis AJ. Late gestation cerebellar growth is rapid and impeded by premature birth. Pediatrics. 2005 Mar;115(3):688-95. doi: 10.1542/peds.2004-1169.

    PubMed 15741373
  • Guihard-Costa AM, Larroche JC. Differential growth between the fetal brain and its infratentorial part. Early Hum Dev. 1990 Jun;23(1):27-40. doi: 10.1016/0378-3782(90)90126-4.

    PubMed 2209474
  • Huppi PS, Warfield S, Kikinis R, Barnes PD, Zientara GP, Jolesz FA, Tsuji MK, Volpe JJ. Quantitative magnetic resonance imaging of brain development in premature and mature newborns. Ann Neurol. 1998 Feb;43(2):224-35. doi: 10.1002/ana.410430213.

    PubMed 9485064
  • Ballabh P, Braun A, Nedergaard M. Anatomic analysis of blood vessels in germinal matrix, cerebral cortex, and white matter in developing infants. Pediatr Res. 2004 Jul;56(1):117-24. doi: 10.1203/01.PDR.0000130472.30874.FF. Epub 2004 May 5.

    PubMed 15128918
  • Arrigoni F, Parazzini C, Righini A, Doneda C, Ramenghi LA, Lista G, Triulzi F. Deep medullary vein involvement in neonates with brain damage: an MR imaging study. AJNR Am J Neuroradiol. 2011 Dec;32(11):2030-6. doi: 10.3174/ajnr.A2687. Epub 2011 Sep 29.

    PubMed 21960491
  • Taoka T, Fukusumi A, Miyasaka T, Kawai H, Nakane T, Kichikawa K, Naganawa S. Structure of the Medullary Veins of the Cerebral Hemisphere and Related Disorders. Radiographics. 2017 Jan-Feb;37(1):281-297. doi: 10.1148/rg.2017160061.

    PubMed 28076020
  • Vilan A, Ribeiro JM, Reis C, Sampaio L. Deep Medullary Veins and Brain Injury. J Pediatr. 2018 Sep;200:290-290.e1. doi: 10.1016/j.jpeds.2018.03.051. Epub 2018 May 3. No abstract available.

    PubMed 29731359
  • du Plessis AJ. Cerebrovascular injury in premature infants: current understanding and challenges for future prevention. Clin Perinatol. 2008 Dec;35(4):609-41, v. doi: 10.1016/j.clp.2008.07.010.

    PubMed 19026331
  • Martinez-Biarge M, Groenendaal F, Kersbergen KJ, Benders MJ, Foti F, Cowan FM, de Vries LS. MRI Based Preterm White Matter Injury Classification: The Importance of Sequential Imaging in Determining Severity of Injury. PLoS One. 2016 Jun 3;11(6):e0156245. doi: 10.1371/journal.pone.0156245. eCollection 2016.

    PubMed 27257863
  • Ramenghi LA, Govaert P, Fumagalli M, Bassi L, Mosca F. Neonatal cerebral sinovenous thrombosis. Semin Fetal Neonatal Med. 2009 Oct;14(5):278-83. doi: 10.1016/j.siny.2009.07.010. Epub 2009 Aug 20.

    PubMed 19699161
  • Nakamura Y, Okudera T, Hashimoto T. Vascular architecture in white matter of neonates: its relationship to periventricular leukomalacia. J Neuropathol Exp Neurol. 1994 Nov;53(6):582-9. doi: 10.1097/00005072-199411000-00005.

    PubMed 7964899
  • Takashima S, Mito T, Ando Y. Pathogenesis of periventricular white matter hemorrhages in preterm infants. Brain Dev. 1986;8(1):25-30. doi: 10.1016/s0387-7604(86)80116-4.

    PubMed 3486608
  • Gould SJ, Howard S, Hope PL, Reynolds EO. Periventricular intraparenchymal cerebral haemorrhage in preterm infants: the role of venous infarction. J Pathol. 1987 Mar;151(3):197-202. doi: 10.1002/path.1711510307.

    PubMed 3572613

Questions about this trial

What is this clinical trial studying?

An observational study of White Matter Injury, run by Shengjing Hospital at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 11 Aug 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Dan Chen, master (+8618940259088, youdrop@sina.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Imaging evaluation of different types of white matter injury in late preterm infants (time frame: 2009.1-2022.12). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04508517, which also lists 22 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Aug 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in